Related Experiment Video
Updated: Jun 17, 2026

08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
A risk-benefit analysis of vaccination
1Division of Pediatric Infectious Diseases, University Children's Hospital Basel, P.O. Box, CH-4005, Basel, Switzerland. Ulrich.Heininger@ukbb.ch
Vaccine
|December 17, 2009
Summary
Population-based immunization programs have successfully reduced infectious diseases. However, public confidence in vaccine safety and necessity is declining, necessitating ongoing risk-benefit evaluations and clear communication.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- Population-based immunization programs have historically achieved significant success in controlling serious infectious diseases globally.
- The success of vaccination campaigns has led to a decrease in disease incidence, inadvertently shifting public attention to perceived vaccine side effects.
- This shift poses a threat to public confidence in the necessity, tolerability, and safety of vaccines.
Purpose of the Study:
- To highlight the challenge posed by waning public confidence in vaccination programs.
- To emphasize the critical need for continuous evaluation of vaccine risks and benefits.
- To underscore the importance of broad communication of scientific findings to maintain public trust in immunization.
Main Methods:
- This study is a review and discussion of the current challenges in maintaining public confidence in vaccination.
- It synthesizes information regarding the impact of successful immunization programs on public perception.
- It emphasizes the necessity of ongoing risk-benefit analyses and transparent communication strategies.
Main Results:
- Successful immunization programs, while beneficial, can paradoxically lead to decreased public engagement and increased focus on vaccine safety concerns.
- Waning public confidence presents a significant dilemma for public health initiatives.
- There is a clear need for robust, ongoing scientific evaluation of vaccines.
Conclusions:
- Continuous evaluation of vaccine risks and benefits is essential for public health.
- Effective and broad communication of scientific evidence is crucial to strengthen public confidence in immunization programs.
- Maintaining trust in vaccines is vital to sustain the success of disease prevention efforts.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Vaccinations
Overview
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
